Sodium-glucose co-transporter-2 inhibition vs. dipeptidyl peptidase-4 inhibition in diabetic kidney transplant recipients: Single center experience

被引：0
|
作者：
Gheith, Osama [1 ]
AlOtaibi, Torki M. [1 ]
Mostafa, Ahmed Y. [1 ]
Shaker, Mohamed [1 ]
Khalid, Mahmoud [1 ]
Emam, Mohamed [1 ]
Mostafa, Mohammed [1 ]
Nagib, Ayman Maher [1 ]
Alserwy, Nabil [1 ]
Othman, Nashwa [1 ]
Dahab, Mohamed [1 ]
Nair, Prasad [1 ]
Denewar, Ahmed [1 ]
机构：
[1] Hamad Alessa OTC, Kuwait, Kuwait
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
441.3
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [31] Comment on 'Sodium-glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease' Reply
    Sarafidis, Pantelis A.
    Ortiz, Alberto
    Ferro, Charles J.
    Halimi, Jean-Michel
    Kreutz, Reinhold
    Mallamaci, Francesca
    Mancia, Giuseppe
    Wanner, Christoph
    JOURNAL OF HYPERTENSION, 2022, 40 (03) : 624 - 626
  • [32] Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis
    Kanie, Takayoshi
    Mizuno, Atsushi
    Takaoka, Yoshimitsu
    Suzuki, Takahiro
    Yoneoka, Daisuke
    Nishikawa, Yuri
    San Tam, Wilson Wai
    Morze, Jakub
    Rynkiewicz, Andrzej
    Xin, Yiqiao
    Wu, Olivia
    Providencia, Rui
    Kwong, Joey S. W.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (10):
  • [33] Sodium-glucose co-transporter-2 inhibitors and the risk of perioperative euglycaemic diabetic ketoacidosis
    Williams, Samuel P.
    Stevens, Jia L.
    Rajendran, Yohinee K.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2022, 83 (11)
  • [34] Real-world evaluation of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus: a retrospective multi-ethnic cohort study
    Louise Gek Huang Goh
    Jiandong Sun
    Benjamin Shao Kiat Ong
    Daphne Khoo
    Chee Fang Sum
    Kwong Ng
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 521 - 555
  • [35] Real-world evaluation of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus: a retrospective multi-ethnic cohort study
    Goh, Louise Gek Huang
    Sun, Jiandong
    Ong, Benjamin Shao Kiat
    Khoo, Daphne
    Sum, Chee Fang
    Ng, Kwong
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 521 - 555
  • [36] Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2i); Shortterm Outcome in Diabetic Kidney Transplant Recipients
    Yagan, Jude
    Mahmoud, Tarek
    Hassan, Amal
    Geith, Osama
    El Serwey, Nabil
    Reda, Suzan
    Mustafa, Mohamed
    Shaker, Mohamed
    AlOtaibi, Torki
    TRANSPLANTATION, 2022, 106 (09) : S320 - S320
  • [37] Sodium-glucose co-transporter 2 inhibition: the saga continues
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2022, 43 (41) : 4215 - 4218
  • [38] Risk of diabetic ketoacidosis with sodium-glucose transporter-2 inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors and sulfonylureas in patients with type 2 diabetes
    Dawwas, Dawwas
    Leonard, Charles E.
    Lewis, James D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 54 - 55
  • [39] Effect of dipeptidyl peptidase-4 inhibitors and sodium-glucose cotransporter-2 inhibitors on retinal complications in type 2 diabetic patients
    Kim, Chungwoon
    Choi, Joong Hyuk
    Yu, Jaeeun
    Chung, Yoo-Ri
    Lee, Kihwang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [40] UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE
    Alistair J. Roddick
    Alexa Wonnacott
    David Webb
    Angela Watt
    Michael A. Watson
    Natalie Staplin
    Alex Riding
    Eirini Lioudaki
    Apexa Kuverji
    Mohsen El Kossi
    Patrick Holmes
    Matt Holloway
    Donald Fraser
    Chris Carvalho
    James O. Burton
    Sunil Bhandari
    William G. Herrington
    Andrew H. Frankel
    BMC Nephrology, 24
12345